drugset

drugset / Trial / NCT00147953

Study to Evaluate the Efficacy of Rituximab in Combination With Low-dose Radiotherapy in Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00147953 ↗

Phase 2 Completed 30 enrolled University of Cologne

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study aims to assess the short term efficacy of a combination of rituximab and low-dose radiotherapy in patients with non-Hodgkin's lymphoma.

Timeline

Start: 2004-06
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rituximab	Monoclonal antibody	—	—

Indications